This illustration shows vials labeled 'COVID-19 Coronavirus Vaccine' alongside a syringe and the J&J logo. It highlights the ongoing supply issues faced by Johnson & Johnson amid EU approvals for new vaccine plants, relevant to recent banking and finance discussions.